Physician profile
John C Brandt
NPI 1730472382
$38,954.79
in general payments reported to CMS, 2019-2025
23 companies · $9,235 in 2025
The $9,235 reported for 2025 was more than what 79% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,978 · 2020: $1,403 · 2021: $886 · 2022: $3,383 · 2023: $10K · 2024: $4,908 · 2025: $9,235.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $13K · Consulting Fee: $5,500 · Travel and Lodging: $3,726 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $13,079.41 |
| Consulting Fee | $5,500.00 |
| Travel and Lodging | $3,725.76 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $12,140.76 | 2019-2025 | Absolute Pro, Ensite, Aveir |
| Boston Scientific Corporation | $10,626.69 | 2019-2025 | General - Crm_crm, Watchman Flx, Farapulse |
| Medtronic, INC. | $5,172.85 | 2021-2025 | Selectsecure, Micra, Azure Xt Dr Mri Surescan |
| Biotronik INC. | $3,433.89 | 2019-2025 | Acticor 7 Vr-T Dx, Plexa Promri, Biomonitor |
| Altathera Pharmaceuticals LLC | $1,922.31 | 2025 | Sotalol Hydrochloride |
| Medtronic Vascular, INC. | $1,194.91 | 2019-2020 | |
| Biosense Webster, INC. | $1,099.84 | 2021-2025 | Carto 3 |
| Impulse Dynamics (USA) INC. | $718.68 | 2024-2025 | Optimizer |
| Atricure, INC. | $391.45 | 2022-2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Boehringer Ingelheim Pharmaceuticals, INC. | $331.33 | 2021-2025 | Jardiance |
| Pfizer INC. | $299.29 | 2022-2025 | |
| Cardiva Medical, INC. | $278.17 | 2019-2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Vektor Medical INC. | $251.64 | 2025 | Vmap |
| Philips North America LLC | $233.01 | 2022-2023 | |
| E.R. Squibb & Sons, L.L.C. | $184.31 | 2024-2025 | Camzyos, Eliquis |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $157.22 | 2020-2025 | Lifevest |
| Elutia, INC. | $141.11 | 2019 | |
| Janssen Pharmaceuticals, INC | $126.93 | 2023-2024 | Xarelto |
| Cordis US Corp. | $114.16 | 2025 | Mynx Control Venous |
| Terumo Medical Corporation | $79.13 | 2021-2024 | Glidewire, Heartrail, Metacross Otw |
| Edwards Lifesciences Corporation | $21.04 | 2024 | Hemosphere |
| Abiomed | $19.72 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.35 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Brandt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.